Carl Zeiss Meditec (ETR:AFX)‘s stock had its “sell” rating reaffirmed by equities research analysts at DZ Bank in a report issued on Wednesday.
AFX has been the topic of several other reports. Nord/LB set a €60.00 ($74.07) price target on shares of Carl Zeiss Meditec and gave the company a “buy” rating in a report on Monday. Hauck & Aufhaeuser set a €62.50 ($77.16) price target on shares of Carl Zeiss Meditec and gave the company a “buy” rating in a report on Thursday, February 8th. Berenberg Bank set a €55.00 ($67.90) price target on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Monday. set a €52.00 ($64.20) target price on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Friday, November 10th. Finally, Commerzbank set a €42.00 ($51.85) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company. Carl Zeiss Meditec has a consensus rating of “Hold” and an average price target of €52.88 ($65.28).
Shares of Carl Zeiss Meditec (ETR:AFX) traded up €0.74 ($0.91) during trading hours on Wednesday, reaching €49.62 ($61.26). 41,846 shares of the company traded hands, compared to its average volume of 93,899. The company has a market cap of $4,410.00 and a P/E ratio of 32.86. Carl Zeiss Meditec has a one year low of €37.35 ($46.11) and a one year high of €55.25 ($68.21).
ILLEGAL ACTIVITY NOTICE: “Carl Zeiss Meditec (AFX) Rating Reiterated by DZ Bank” was published by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/14/carl-zeiss-meditec-afx-rating-reiterated-by-dz-bank.html.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.